| GWPDX | RGWBX | GWPDX / RGWBX | |
| Total Expense Ratio | 0.38 | 1.46 | 26% |
| Annual Report Gross Expense Ratio | 0.38 | 1.46 | 26% |
| Fund Existence | 9 years | 14 years | - |
| Gain YTD | 17.707 | 18.899 | 94% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 250 | 400,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 24.9B | 24.9B | 100% |
| Annual Yield % from dividends | 0.64 | 0.00 | - |
| Returns for 1 year | 10.19 | 10.54 | 97% |
| Returns for 3 years | 52.15 | 48.84 | 107% |
| Returns for 5 years | 37.87 | 34.10 | 111% |
| Returns for 10 years | N/A | 94.79 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FBT | 203.02 | 1.08 | +0.53% |
| First Trust NYSE Arca Biotech ETF | |||
| MYCM | 25.03 | N/A | N/A |
| SPDR SSGA My2033 Corporate Bond ETF | |||
| FOPC | 25.85 | -0.02 | -0.08% |
| Frontier Asset Opportunistic Credit ETF | |||
| MMCA | 21.85 | -0.03 | -0.14% |
| NYLI MacKay California Muni Intmdt ETF | |||
| MMT | 4.72 | -0.02 | -0.42% |
| MFS Multimarket Income Trust | |||